Peter Bryson

1.1k total citations
25 papers, 817 citations indexed

About

Peter Bryson is a scholar working on Surgery, Reproductive Medicine and Epidemiology. According to data from OpenAlex, Peter Bryson has authored 25 papers receiving a total of 817 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 10 papers in Reproductive Medicine and 8 papers in Epidemiology. Recurrent topics in Peter Bryson's work include Ovarian cancer diagnosis and treatment (10 papers), Endometrial and Cervical Cancer Treatments (8 papers) and Cervical Cancer and HPV Research (8 papers). Peter Bryson is often cited by papers focused on Ovarian cancer diagnosis and treatment (10 papers), Endometrial and Cervical Cancer Treatments (8 papers) and Cervical Cancer and HPV Research (8 papers). Peter Bryson collaborates with scholars based in Canada, United States and United Kingdom. Peter Bryson's co-authors include Thomas R. Oliver, Hal W. Hirte, Michael Fung‐Kee‐Fung, Laurie Elit, Amit M. Oza, Michael Fung Kee Fung, Mary Johnston, Shailendra Verma, Mark S. Carey and Allan Covens and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Peter Bryson

24 papers receiving 793 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Bryson Canada 12 353 318 250 218 215 25 817
Robert Grimshaw Canada 16 415 1.2× 214 0.7× 303 1.2× 246 1.1× 207 1.0× 23 869
Kristina Hellman Sweden 21 275 0.8× 243 0.8× 233 0.9× 319 1.5× 287 1.3× 55 1.0k
Arto Leminen Finland 23 628 1.8× 304 1.0× 249 1.0× 270 1.2× 348 1.6× 38 1.2k
Abbie L. Fields United States 19 454 1.3× 325 1.0× 318 1.3× 488 2.2× 272 1.3× 43 1.2k
Jae Yun Song South Korea 19 391 1.1× 253 0.8× 233 0.9× 300 1.4× 291 1.4× 80 1.1k
Ate GJ van der Zee Netherlands 9 237 0.7× 181 0.6× 187 0.7× 397 1.8× 212 1.0× 13 794
Ming-Shyen Yen Taiwan 18 512 1.5× 386 1.2× 160 0.6× 518 2.4× 190 0.9× 49 1.1k
Al Covens Canada 16 341 1.0× 197 0.6× 167 0.7× 478 2.2× 204 0.9× 40 914
Sheldon Weiner United States 16 502 1.4× 239 0.8× 173 0.7× 444 2.0× 125 0.6× 29 912
N. Einhorn Sweden 15 559 1.6× 317 1.0× 199 0.8× 285 1.3× 111 0.5× 35 967

Countries citing papers authored by Peter Bryson

Since Specialization
Citations

This map shows the geographic impact of Peter Bryson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Bryson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Bryson more than expected).

Fields of papers citing papers by Peter Bryson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Bryson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Bryson. The network helps show where Peter Bryson may publish in the future.

Co-authorship network of co-authors of Peter Bryson

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Bryson. A scholar is included among the top collaborators of Peter Bryson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Bryson. Peter Bryson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bryson, Peter, Qingzhu Jia, Gang Chen, et al.. (2019). HPV16 E6-specific TCR-T armored with checkpoint blockade in the treatment of cervical cancer. Annals of Oncology. 30. v502–v502. 3 indexed citations
2.
Bryson, Peter, et al.. (2016). Outcomes of a Decade of Routine Cervical Screening in a Canadian Adolescent Obstetrics Clinic. Journal of Obstetrics and Gynaecology Canada. 38(1). 51–55. 7 indexed citations
3.
Fung, Michael Fung Kee, et al.. (2014). Screening Postmenopausal Women for Ovarian Cancer. 1 indexed citations
4.
5.
Molckovsky, Andrea, Suresh Vijay, Wilma M. Hopman, et al.. (2008). Decreased dose density of standard chemotherapy does not compromise survival for ovarian cancer patients. International Journal of Gynecological Cancer. 18(1). 8–13. 1 indexed citations
6.
Molckovsky, Andrea, et al.. (2007). Decreased dose density of standard chemotherapy does not compromise survival for ovarian cancer patients. International Journal of Gynecological Cancer. 18(1). 8–13. 4 indexed citations
7.
Fung‐Kee‐Fung, Michael, Thomas R. Oliver, Laurie Elit, et al.. (2007). Optimal Chemotherapy Treatment for Women with Recurrent Ovarian Cancer. Current Oncology. 14(5). 195–208. 184 indexed citations
8.
Bryson, Peter, et al.. (2007). RETIRED: Vaccines. Journal of Obstetrics and Gynaecology Canada. 29(8). S51–S54. 2 indexed citations
9.
Bentley, J., Monique Bertrand, Peter Bryson, et al.. (2006). RETIRED: Guidelines for Training Requirements in Colposcopy and its Related Treatment Modalities. Journal of Obstetrics and Gynaecology Canada. 28(4). 314–316. 2 indexed citations
10.
Faught, Wylam, John Jeffrey, Peter Bryson, et al.. (2006). Management of Squamous Cell Cancer of the Vulva. Journal of Obstetrics and Gynaecology Canada. 28(7). 640–645. 12 indexed citations
11.
Usmani, Nawaid, Farshad Foroudi, Jenny Du, et al.. (2005). An evidence-based estimate of the appropriate rate of utilization of radiotherapy for cancer of the cervix. International Journal of Radiation Oncology*Biology*Physics. 63(3). 812–827. 16 indexed citations
12.
Bryson, Peter, et al.. (2004). Is electrosurgical loop excision with negative margins sufficient treatment for cervical ACIS?. Gynecologic Oncology. 93(2). 465–468. 35 indexed citations
13.
Fung, Michael Fung Kee, Peter Bryson, Mary Johnston, & Alexandra Chambers. (2004). Screening Postmenopausal Women for Ovarian Cancer: A Systematic Review. Journal of Obstetrics and Gynaecology Canada. 26(8). 717–728. 26 indexed citations
14.
Covens, Allan, Mark S. Carey, Peter Bryson, et al.. (2002). Systematic Review of First-Line Chemotherapy for Newly Diagnosed Postoperative Patients with Stage II, III, or IV Epithelial Ovarian Cancer. Gynecologic Oncology. 85(1). 71–80. 108 indexed citations
15.
Hoskins, Paul, Elizabeth A. Eisenhauer, Sandra Beare, et al.. (1998). Randomized phase II study of two schedules of topotecan in previously treated patients with ovarian cancer: a National Cancer Institute of Canada Clinical Trials Group study.. Journal of Clinical Oncology. 16(6). 2233–2237. 142 indexed citations
16.
Rusthoven, James J., Leslie Levin, J. Mazurka, et al.. (1991). Two Phase I Studies of Carboplatin Dose Escalation in Chemotherapy-Naive Ovarian Cancer Patients Supported With Patients Supported With Granulocyte-Macrophage Colony-Stimulating Factor. JNCI Journal of the National Cancer Institute. 83(23). 1748–1753. 23 indexed citations
17.
Rusthoven, James J., L Levin, E. Eisenhauer, et al.. (1991). A phase I study of GM-CSF, cyclophosphamide (CP), and escalating doses of carboplatin (CBDCA) in chemotherapy-Naïve patients with ovarian cancer. Gynecologic Oncology. 40(2). 169–170. 2 indexed citations
18.
Bryson, Peter, A.J. Dembo, Terence J. Colgan, et al.. (1991). Invasive squamous cell carcinoma of the vulva: defining low and high risk groups for recurrence. International Journal of Gynecological Cancer. 1(1). 25–31. 13 indexed citations
19.
20.
Thomas, Gillian, A.J. Dembo, A.D. DePetrillo, et al.. (1989). Concurrent radiation and chemotherapy in vulvar carcinoma. Gynecologic Oncology. 34(3). 263–267. 109 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert Grimshaw Breakdown of academic impact, for papers by Kristina Hellman Breakdown of academic impact, for papers by Arto Leminen Breakdown of academic impact, for papers by Abbie L. Fields Breakdown of academic impact, for papers by Jae Yun Song Breakdown of academic impact, for papers by Ate GJ van der Zee Breakdown of academic impact, for papers by Ming-Shyen Yen Breakdown of academic impact, for papers by Al Covens Breakdown of academic impact, for papers by Sheldon Weiner Breakdown of academic impact, for papers by N. Einhorn
Rankless by CCL
2026